Published in Panminerva Med on July 10, 1989
A lysosome-centered view of nutrient homeostasis. Autophagy (2016) 0.76
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev (1995) 4.94
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature (2000) 3.36
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest (2006) 3.17
Id proteins at the cross-road of development and cancer. Oncogene (2001) 1.90
Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol (1996) 1.81
Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler (1997) 1.65
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J Neurol Neurosurg Psychiatry (2009) 1.64
Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem (1996) 1.58
Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy. J Endocrinol Invest (2004) 1.49
Circulating ghrelin levels in the newborn are positively associated with gestational age. Clin Endocrinol (Oxf) (2004) 1.44
Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH Registry. J Endocrinol Invest (2006) 1.39
Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet (1995) 1.35
Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene (1998) 1.34
Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach. Clin Endocrinol (Oxf) (2008) 1.30
Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol (1999) 1.27
Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci U S A (2001) 1.15
Depressive symptoms in adult coeliac disease. Scand J Gastroenterol (1998) 1.14
Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab (2001) 1.11
Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum Genet (1997) 1.08
A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. J Neurol Neurosurg Psychiatry (2003) 1.08
Evaluation of evoked potentials and lymphocyte subsets as possible markers of multiple sclerosis: one year follow up of 30 patients. J Neurol Neurosurg Psychiatry (1986) 1.05
Prospective study of multiple sclerosis with early onset. Mult Scler (2002) 1.05
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler (2008) 1.02
Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene (1997) 1.02
Anosognosia, intrusions and 'frontal' functions in Alzheimer's disease and depression. Neuropsychologia (1995) 1.01
Neonatal transient hypothyroidism: aetiological study. Italian Collaborative Study on Transient Hypothyroidism. Arch Dis Child Fetal Neonatal Ed (1998) 1.00
Prognostic role of depression after lumbar disc surgery. Neurol Sci (2004) 1.00
Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry (2001) 0.99
Tetrahydrobiopterin non-responsiveness in dihydropteridine reductase deficiency is associated with the presence of mutant protein. J Inherit Metab Dis (1986) 0.99
Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res (1995) 0.99
The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis. Eur Neurol (1987) 0.98
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children. Clin Endocrinol (Oxf) (2006) 0.98
Motor potentials of bulbocavernosus muscle after transcranial and lumbar magnetic stimulation: comparative study with bulbocavernosus reflex and pudendal evoked potentials. J Neurol Neurosurg Psychiatry (1991) 0.97
Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Cancer Res (1996) 0.97
Hyperthermal molecular beam deposition of highly ordered organic thin films. Phys Rev Lett (2003) 0.96
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology (1999) 0.91
Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes (2001) 0.91
The incidence of type 1 diabetes is increasing in both children and young adults in Northern Italy: 1984-2004 temporal trends. Diabetologia (2009) 0.91
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results. Neurol Sci (2007) 0.90
Epilepsy in multiple sclerosis. Eur Neurol (1990) 0.90
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients. J Neurol (2012) 0.89
Suppression of near-Fermi level electronic states at the interface in a LaNiO3/SrTiO3 superlattice. Phys Rev Lett (2011) 0.89
Foetal and neonatal thyroid disorders. Minerva Pediatr (2002) 0.89
Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group. Neurol Sci (2011) 0.88
Detoxification process for glutaraldehyde-treated bovine pericardium: biological, chemical and mechanical characterization. J Heart Valve Dis (1998) 0.88
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult Scler (2005) 0.88
Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. Eur J Endocrinol (2004) 0.87
Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest (2005) 0.87
Noonan-like syndrome with loose anagen hair associated with growth hormone insensitivity and atypical neurological manifestations. Am J Med Genet A (2012) 0.87
Telecare for teenagers with type 1 diabetes: a trial. Minerva Pediatr (2007) 0.87
Safety and efficacy of natalizumab in children with multiple sclerosis. Neurology (2010) 0.87
Puberty onset in Northern Italy: a random sample of 3597 Italian children. J Endocrinol Invest (2005) 0.86
Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study. Med Pediatr Oncol (1995) 0.86
Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo. Cancer Res (2000) 0.86
A systematic review of Helicobacter pylori eradication treatment schedules in children. Aliment Pharmacol Ther (2000) 0.86
Infants of immigrant parents in Italy. A national multicentre case control study. Panminerva Med (2001) 0.86
Prevalence and risk factors for overweight and obesity in a population of Italian schoolchildren: a longitudinal study. J Endocrinol Invest (2008) 0.85
Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab (2001) 0.85
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Mult Scler (2009) 0.84
Early onset of gastric carcinoma and constitutional deletion of 18p. Cancer Genet Cytogenet (1999) 0.84
Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins. Mult Scler (2007) 0.84
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma. J Neurooncol (1997) 0.84
Vitamin D levels in a paediatric population of normal weight and obese subjects. J Endocrinol Invest (2014) 0.84
Cerebral involvement in celiac disease: a serial MRI study in a patient with brainstem and cerebellar symptoms. Neurology (1997) 0.83
Thyroid autoimmunity: really an important cause of sporadic congenital hypothyroidism? Panminerva Med (1992) 0.83
Dyscalculia in the early stages of Alzheimer's disease. Acta Neurol Scand (1999) 0.83
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate. Mult Scler (2009) 0.83
Growth hormone receptor gene mutations in two Italian patients with Laron Syndrome. J Endocrinol Invest (2007) 0.83
The use of local reference growth charts for clinical use or a universal standard: a balanced appraisal. J Endocrinol Invest (2012) 0.83
Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica (1991) 0.82
Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet. J Endocrinol Invest (2011) 0.82
Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses. Neurology (2002) 0.82
A novel taxane active against an orthotopically growing human glioma xenograft. Cancer (2001) 0.81
DHPR deficiency in Italy. J Pediatr (1984) 0.81
Growth hormone therapy for short children born small for gestational age. Horm Res (2007) 0.81
Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis. Med Pediatr Oncol (1993) 0.81
Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743. Eur J Cancer (2005) 0.81
Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med (1996) 0.81
Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux. Eur J Cancer (1995) 0.81
Growth hormone, insulin-like growth factor-I and somatostatin in human fetus, newborn, mother plasma and amniotic fluid. Panminerva Med (1994) 0.81
Etiopathogenetic advances and management of holoprosencephaly: from bench to bedside. Panminerva Med (2010) 0.81
Neurotransmitter therapy and diet in malignant phenylketonuria. Eur J Pediatr (1987) 0.80
Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis. Ital J Neurol Sci (1984) 0.80
Effects of iopamidol on neonatal thyroid function. Eur J Radiol (1992) 0.80
Screening for malignant phenylketonuria. Lancet (1987) 0.80
The prognosis of idiopathic optic neuritis. Neurol Sci (2000) 0.80
Wolman's disease: clinical and biochemical findings of a new case. J Inherit Metab Dis (1988) 0.80
Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol (1997) 0.80
Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci (2001) 0.80
Ghrelin secretion in preterm neonates progressively increases and is refractory to the inhibitory effect of food intake. J Clin Endocrinol Metab (2006) 0.80